相关实验视频

Updated: May 26, 2025

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

Published on: May 17, 2024

对整体和乳腺癌特异性存活率立即进行乳房重建:倾向性得分匹配分析

Qianrui Xu¹, Yuntian Wan², Zhangyue Sun³

¹Department of Breast Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Breast (Edinburgh, Scotland)

|February 22, 2025

概括

与单独的乳房切除术 (MA) 相比,立即乳房重建 (IBR) 改善了整体存活率 (OS) 和乳腺癌特定存活率 (BCSS). 这种生存益处在大多数患者群体中都可见,尽管在某些人口统计学群体中吸收率有所不同.

科学领域:

在瘤学瘤学.
手术瘤学手术瘤学
整形外科整形外科整形外科

背景情况:

乳房切除术后的乳房重建的趋势越来越大.
专注于改善患者的治疗结果和生活质量.
立即乳房重建 (IBR) 与单独切除乳房 (MA) 的比较.

研究的目的:

评估IBR对生存结果的影响.
为了比较IBR和MA之间的整体存活率 (OS) 和乳腺癌特定存活率 (BCSS).
确定从IBR中受益或使用不足的患者子组.

主要方法:

回顾性队列研究 (2010-2015年).
20-79岁的患者接受MA或IBR.
倾向性得分匹配 (PSM) 用于队列平衡.
对OS和BCSS的生存分析与子组分析.

主要成果:

随访时间中位数为93个月,共16220名匹配患者.
IBR显著改善了OS (HR 0.74) 和BCSS (HR 0.84) 与MA相比.
在不同小组 (年龄,阶段,治疗状态) 中观察到的OS优势.
放射治疗患者不太可能接受IBR; 特定的人口结构尽管有生存益处,但仍未充分利用IBR.

结论:

在所有分析的患者层面上,IBR为MA提供了普遍的OS优势.
某些患者群体 (老年人,黑人族裔,低收入,需要放射治疗) 可以从IBR中受益,但不优先接受.
需要进一步调查代表性不足群体中IBR的障碍和促进因素.

关键词:

乳腺癌乳腺癌乳腺癌立即进行乳房重建.进行乳腺切除术.在 SEER 数据库中,我们可以看到对生存分析的分析.

更多相关视频

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on: February 6, 2020

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Comparing the Survival Analysis of Two or More Groups

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...

Kaplan-Meier Approach

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...